Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:37 PM
Ignite Modification Date: 2025-12-25 @ 9:27 PM
NCT ID: NCT01729156
Description: None
Frequency Threshold: 0
Time Frame: During the 90 days trial
Study: NCT01729156
Study Brief: Effects of Metformin on Hepatic FFA Metabolism
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Healthy Controls Healthy controls receiving 1000 mg metformin twice daily for 3 months Metformin: 1000 mg metformin twice daily in 3 months 0 None 0 12 1 12 View
Placebo Placebo Placebo: 2 tablets twice daily in 3 months 0 None 0 12 1 12 View
Metformin Metformin "Teva", 1000 mg twice daily for 3 months Metformin: 1000 mg metformin twice daily in 3 months 0 None 0 12 0 12 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Gastrointestinal uncomfort NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Fractured vertebral column NON_SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders None View